本页面由Tiger Trade Technology Pte. Ltd.提供服务

HCW Biologics Inc.

1.53
-0.0750-4.69%
成交量:3.21万
成交额:4.96万
市值:341.04万
市盈率:-0.06
高:1.58
开:1.55
低:1.51
收:1.60
52周最高:27.57
52周最低:1.50
股本:223.63万
流通股本:204.98万
量比:0.87
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):-27.1846
每股收益(LYR):-63.7804
净资产收益率:-151.36%
总资产收益率:-13.88%
市净率:0.46
市盈率(LYR):-0.02

数据加载中...

2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/17

重要事件披露

Form 8-K - Current report
2026/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/12

SEC问询函

Form CORRESP - Correspondence
2026/02/12

SEC问询函

Form CORRESP - Correspondence
2026/02/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933